Covered recipient · General Payments record
CONCETTA C CRISCOLA
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2023–2024
$2,056.29
- Reported across 86 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,128.31 | 56 |
| Education | $164.99 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $203.15 | 5 |
| Celgene Corporation | $85.22 | 4 |
| PFIZER INC. | $82.81 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $79.55 | 3 |
| Acerta Pharma LLC | $76.96 | 3 |
| SOBI, INC | $69.99 | 1 |
| Astellas Pharma US Inc | $65.00 | 3 |
| Incyte Corporation | $62.40 | 3 |
| Merck Sharp & Dohme Corporation | $61.03 | 3 |
| ARRAY BIOPHARMA INC | $60.01 | 5 |
| JAZZ PHARMACEUTICALS INC. | $58.20 | 3 |
| Rigel Pharmaceuticals, Inc. | $56.80 | 5 |
| E.R. Squibb & Sons, L.L.C. | $52.76 | 2 |
| GlaxoSmithKline, LLC. | $34.74 | 2 |
| EMD Serono, Inc. | $32.56 | 1 |
| Octapharma USA, Inc. | $25.07 | 1 |
| Regeneron Healthcare Solutions, Inc. | $22.84 | 1 |
| Coherus Biosciences Inc. | $21.61 | 1 |
| EISAI INC. | $21.02 | 1 |
| ADC Therapeutics America, Inc. | $20.36 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.09 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $19.66 | 1 |
| Phadia US Inc. | $17.12 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $17.12 | 1 |
| Stemline Therapeutics Inc. | $14.05 | 1 |
| Amneal Pharmaceuticals LLC | $13.18 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (58)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.